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Abstract Background Liver regeneration is still not fully
understood. Partial liver transplantation (LT) can provide the
opportunity to investigate the mechanisms of liver regenera-
tion, including the contribution of extrahepatic cells to liver
regeneration.MethodsOf61patientstransplantedwithpartial
liver graft between August 1997 and October 2006, 56
patients were studied, including 49 adults and 7 children.
Sequential computed tomography volumetric analysis was
performed for volume measurement, while proliferating cell
nuclear antigen (PCNA) labeling index was investigated for
liver cell proliferation innonprotocol liver biopsyspecimens.
In addition, 15 male recipients who had female liver grafts
were investigated in order to detect Y chromosomes as
extrahepatic cells in nonprotocol liver biopsy specimens.
ResultsGraftvolumeperstandardlivervolumewasmarkedly
increased after adult-to-adult living-donor (LD) LT. In pedi-
atric transplants, there was no volume increase over time.
PCNAlabelingindexwasvigorousinadult-to-adultLDLTin
the early period after LDLT. No Y chromosome was evident
in hepatocytes from female-donor male-recipient grafts dur-
ingorafterliverregeneration.However,inthecasesoffailing
grafts of this type, many Y-chromosome-positive cells were
observed in the graft liver. The character of those cells was
CD34(-), CK9(-), hepatocyte-speciﬁc antigen(-), and
CD68(?/-). Conclusion In adult-to-adult LDLT, vigorous
liver regeneration occurs in the graft liver, demonstrated by
not only volumetric but cell kinetic analysis. Involvement of
extrahepatic cells in normal liver regeneration seems limited.
Keywords Living-donor liver transplantation 
Liver regeneration  Extrahepatic cells
Introduction
The mechanism of liver regeneration is still not fully
understood. Although vigorous liver regeneration after
living-donor liver transplantation (LDLT) has been repor-
ted by us and others [1–3], it has been assessed by imaging
studies such as computed axial tomography (CAT) scan,
not hepatocyte cell division. In the present study, we took
the opportunity to use liver biopsy specimens to verify liver
regeneration in partial liver recipients during various
periods after LDLT.
In addition, during liver regeneration it has been reported
that extrahepatic cells, especially bone marrow (BM)-
derived cells, are mobilized and involved [4–6]. However,
details regarding how extrahepatic cells are involved and
how much they contribute to normal liver regeneration have
not been fully elucidated [7–10]. Therefore, we investigated
liver biopsy specimens from female-donor male-recipient
grafts, in which only XX cells should be present in the graft
liver. We used ﬂuorescent in situ hybridization (FISH) to
detect Y chromosomes in the liver to identify extrahepatic
cells in the liver upon liver regeneration.
Materials and Methods
Patients
Of 61 patients who underwent LDLT between August 1997
and October 2006 at Nagasaki University Hospital, 56 Jap-
anese patients with survival times of more than 3 months
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right lobe grafts were transplanted in 40 recipients, while
left-side grafts (8 extended left lobe graft, 1 left lobe graft)
were performed in 9 recipients. Seven pediatric cases with
leftlaterallobegraftalsounderwentvolumetricstudy.Adult
patients were deﬁned as those over 16 years old. When liver
function test was deranged, total 93 liver biopsies were
carriedout,consistingof83inadultcasesand10inpediatric
cases, and were prepared for proliferative cell nuclear anti-
gen (PCNA) staining. Within these, a total of 24 liver
biopsies were performed in 15 recipients on indication from
a pool of 19 male recipients (XY) who were transplanted
with female livers (XX).
Methods of LDLT
All partial liver grafts were preserved in University of
Wisconsin solution and implanted using a piggyback
technique. In general, graft selection was based on the
results of volumetric studies using CAT scans to obtain
ratios of graft volume to standard liver volume of more
than 35% in the recipients.
A dual or triple immunosuppressive regimen was used,
which included tacrolimus or cyclosporine A, steroid, and
mycophenolate mofetil. Patients with compromised renal
function were given induction therapy with interleukin-2
antibodies. Biopsy-proven rejections were treated if clin-
ical and laboratory signs mandated steroid bolus
treatment. Steroid-resistant rejections were treated with
OKT3.
Investigation for Liver Regeneration
Incremental growth of the liver in volume was measured by
serial CAT scans using Flexi Trace software (Tree Star,
Inc., U.S.A.) at 0, 1–2 weeks, and 3 months after LDLT
[1]. In liver biopsy specimens, expression of PCNA
(DACO, Carpinteria, CA) was analyzed for intrahepatic
proliferation [11].
Four-micrometer liver sections were deparafﬁnized in
xylene and hydrated in graded ethanol. After deparafﬁni-
zation, rehydration, and heating in 95C buffer, sections
were incubated with each antibody and subsequently with
Histoﬁne Simple Stain MAX-PO (MULTI) (Nichirei,
Japan). Incubation was performed overnight at 4C and
followed by a wash in three changes of phosphate buffered
saline (PBS) for 5 min. For all stainings, the reaction
product was developed with the use of 3-diaminobenzidine
tetrahydrochloride and H2O2. The sections were counter-
stained with Meyer hematoxylin–eosin.
For hepatocyte staining, the goat anti-human hepato-
cyte-speciﬁc antigen Ab (R&D system, Minneapolis, MN),
and 2nd Ab biotinylated rabbit anti-goat Ig (DAKO, Car-
pinteria, CA) were used. For the staining of CK7 (bile duct
marker), CD68 (macrophage marker) and CD34 (hemato-
poietic cells) were used, respectively, according to the
manufacturer’s protocol.
Fluorescent In Situ Hybridization (FISH)
FISH was performed in our reference laboratory (SRL,
Nagasaki, Japan). Sections from parafﬁn-embedded biop-
sied liver tissues were placed on silane-coated glass slides.
The slides were deparafﬁnized immediately in two rinses
of 1,000 g/l xylene for 10 min each. Each slide was
rehydrated in an ethanol series for 5 min. The slides were
then treated with 0.2 mol/l HCl for 20 min, followed by
2 9 SSC (0.3 mol/l sodium chloride and 0.03 mol/l
sodium citrate) for 20 min at 80C, treated with 0.05 mg/
ml proteinase K in TEN [0.05 mol/l Tris–HCl, pH 7.8,
0.01 mol/l ethylenediamine tetraacetic acid (EDTA), and
0.01 mol/l sodium chloride] for 10 min at 37C, and placed
in 40 g/l formaldehyde in PBS for 10 min. Both FISH
probes and target DNA were denatured simultaneously for
10 min at 90C, and the slides were incubated overnight at
42C, placed in 2 9 SSC for 10 min at 42C, washed twice
in 2 9 SSC/500 g/l formaldehyde formamide for 5 min
each at 42C, washed 2 9 SSC for 5 min at 42C, and
counterstained in 2 9 SSC/0.03 lg/ml 4’,6-diamidino-2-
phenylindole (DAPI).
Statistical Analysis
For the data, Mann–Whitney U test was used. Differences
were considered statistically signiﬁcant for P-value less
than 0.05.
Results
Liver Volume
Graft volume per standard liver volume at 0, 1, 3, and
6 months after adult-to-adult LDLT was 53.2%, 95.9%,
98.5%, and 101.2% in right lobe grafts and 41.1%, 81.9%,
92.7%, and 102.4% in left-sided grafts, respectively
(Fig. 1). Since volume changes in pediatric LDLT were not
evident, they are not included in the ﬁgure.
DNA Synthesis in the Liver
PCNA labeling index was vigorous in adult-to-adult LDLT
in the early period after LDLT, while it was not evident in
pediatric LDLT (Fig. 2).
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for Y-Positive Cells
Y chromosome was not evident in hepatocytes of female-
donor male-recipient grafts after normal liver regeneration
in adult-to-adult LDLT recipients (Fig. 3, case 1). As seen
in this case, when graft livers did not receive any damage
and underwent normal liver regeneration, existence of Y-
chromosome-positive cells was limited with FISH exami-
nation. However, in the case of failing graft, such as in
cases 11–13, many Y-chromosome-positive cells were
observed in zone 1 of the graft liver (Fig. 3, case 11).
For these cases, immunohistochemical staining was per-
formedintheareawithYchromosomes.CD34(-),CK9(-),
hepatocyte Ag(-), and CD68(?/-) were observed using
immunohistochemical staining (Fig. 4, case 11). In the case
of chronic liver damage (Fig. 5, case 15) after LDLT due to
biliary complication, a few Y-positive cells were also
detected with nonspeciﬁc staining for CD34, CK9, hepato-
cyte Ag, and CD68. Results of immunohistochemical
staining are summarized in Tables 1 and 2.
Discussion
In this report, we showed liver regenerative response after
partial LT using not only volumetric CAT scan study but
also PCNA labeling of biopsy specimens. Previously, we
reported vigorous liver regenerative response after partial
liver regeneration and investigated liver regenerative
growth factors after liver regeneration [11]. Herein, we
showed a clear difference in proliferation of graft liver
according to recipient body size and blood ﬂow due to the
difference in responses when transplanted in adults and
children with different standard liver volumes. We did not
carry out statistical analysis on PCNA index since it
exhibited wide deviation. Liver regeneration remains an
unsolved phenomenon, but our results show that it could be
related to factors in recipients, as we reported previously
[1]. Since protocol biopsy tends to be avoided because of
risk of hemorrhage etc., further investigation is needed to
assess cell proliferation noninvasively aside from CAT
scan. Also since liver biopsy was not done on protocol,
rejection or inﬂammation could have affected the data of
PCNA staining. Although it would be interesting to
investigate the difference in liver regeneration between
patients after liver resection and those after partial liver
transplantation, biopsy specimen from patients after liver
resection cannot be obtained because of risk of complica-
tions. Therefore this also remains for further investigation.
Our liver specimens from liver transplant recipients were
obtained because of on-demand liver biopsy.
In addition, for combinations of female donor (XX) and
male recipient (XY), the Y chromosome was investigated
in the biopsy specimen of the female liver (XX) in order to
investigate the contribution of extrahepatic cells to liver
regeneration. Previously, in an in vivo experiment con-
ducted in 2000, it was reported that hepatocytes could be
derived from BM cells [12]. Subsequently, in 2001, Bac-
carani et al. [13] reported that, in human recipients,
replacement of a female liver venous endothelium with
male BM showed the possibility of involvement of BM
cells in liver rearrangement. Fujii et al. [4] reported that
BM cells participated in liver regeneration after hepatec-
tomy, whereas the majority of cells were committed to
sinusoidal endothelial cells. Very recently, Conzelmann
et al. [5], using their reduced-size LT model, reported that
recipient-derived progenitor cells were present and might
contribute to liver regeneration in mice. However, in 2005
Di Campli et al. [7] reported no evidence of hematopoietic
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Fig. 1 Liver regeneration of right lobe or left lobe graft liver after
adult-to-adult LDLT using volumetric analysis using CAT scan.
LDLT living-donor liver transplantation, CAT computed axial
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Fig. 2 PCNA labeling index after LDLT using immunohistochemical
staining. PCNA proliferating cell nuclear antigen, LDLT living-donor
liver transplantation
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123stem cell mobilization in patients who underwent hepa-
tectomy or in patients with acute liver failure. Similarly, in
2006, Moritoki et al. [8], using green ﬂuorescent protein
transgenic mice, demonstrated that BM cell transfer
seemed not to contribute to the differentiation of cholan-
giocytes in a chronic cholestasis model. In 2007,
Tomiyama [6] reported the limited contribution of cells
originating from intact extrahepatic tissue in hepatocyte
regeneration in transplanted rat livers. Thus, it is still
unknown whether extrahepatic cells such as BM cells
could contribute to liver regeneration or liver repair,
especially in humans.
In our study, we did not ﬁnd many Y-chromosome-
positive cells after liver transplantation with normal liver
regeneration. If extrahepatic cells had been involved and
integrated into normal liver regeneration, they should have
stayed and been found in the liver biopsied a long time
after LDLT. This is indirect evidence that would seem to
rule out extrahepatic cell contribution to normal liver
regeneration in humans, in contrast to previous reports [12,
13]. On the other hand, when failing livers were biopsied,
many Y-chromosome-positive cells were present. Although
we could not clearly show the origin of those Y-positive
cells, circulating macrophages were candidate sources
A: At LDLT, GV/SLV 31.3% B: 4Y post LDLT , GV/SLV 85.8%
C: 1w post LDLT, GV/SLV 44.4%
Case 1: normal liver regeneration
Case 11:  acute cellular rejectionዘgraft failure
D: 1w post LDLT
Fig. 3 FISH for Y chromosome
in liver biopsy specimens.
Case 1 showed normal liver
regeneration after LDLT. a At
the time of LDLT, few Y-
chromosome-positive cells were
seen. b With time, although GV/
SLV increased, a few Y-
chromosome-positive cells were
seen only in the sinusoid.
c Case 11 had severe acute
rejection at 1 week after LDLT.
d In the biopsy specimen,
massive accumulation of
Y-chromosome-positive cells
was seen, mimicking hepatic
structure. FISH ﬂuorescent
in situ hybridization, GV/SLV
graft volume versus standard
liver volume ratio
F. CD34  (hematopoietic)
B. Hepatocyte Antigen C. CK7 (bile duct)
E. CD68 (macrophage) 
A. FISH
D. Hematoxylene and Eosin
Fig. 4 Immunohistochemical stainings in case 11. Characterization
of Y-chromosome-positive cells was attempted in corresponding area.
a FISH showing Y-chromosome-positive cells (white square), b
hepatocyte antigen was not positive in the black square, c CK7
(cytokeratin 7, bile duct) was not positive in the black square, d
hematoxylin and eosin staining, e CD68 (macrophage) was partially
positive in the black square, f CD34 (hematopoietic cell) was not
positive in the black square
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123because some cells were positive for CD68, which we used
to identify macrophages. However, CD34, used for hema-
topoietic cells, was negative, which indicated that those
Y-positive cells did not have hematopoietic origins. In
addition, there may be signiﬁcant sampling variability in
liver biopsy specimens from a single liver biopsy, which
may not necessarily be representative of the entire liver. In
liver chronically damaged by biliary complication,
Y-chromosome-positive cells were not as numerous as seen
in the case of acute graft failure. In addition, despite the
information about expression of progenitor cell markers
such as c-kit and Thy-1, we did not investigate this in this
study; this awaits further investigation. With regard to
CD68(?) Y chromosome(?) cells, we presume that they
are regular macrophages from recipient side to dispose of
damaged cells in failing liver, not special multipotent stem
cells expressing CD68.
E. CD34 (hematopoietic)
A. 1.5Y after LDLT C. CK7 (bile duct) B. Azan (fibers)
D. CD68 (macrophage)
Fig. 5 Immunohistochemical
stainings in case 15, secondary
biliary cirrhosis after LDLT. a
FISH showing Y-chromosome-
positive cells (white square),
b Azan staining was positive,
showing the presence of liver
ﬁbrosis, c CK7 (cytokeratin 7,
bile duct) was not positive in the
black square, d CD68
(macrophage) was partially
positive in the black square,
e CD34 (hematopoietic cell)
was not positive in the black
square. LDLT living-donor liver
transplantation
Table 1 Demographics of male recipients with female donors
Case no. Age Gender Etiology Donor Blood type match Graph type Biopsy period after LDLT Comments Outcome
1 16 M FHF Mother Identical L 3d, 4Y None Survived
2 5 M BA Mother Identical LL 2M, 8Y Cholestasis Survived
3 56 M LC-B/HCC Sister Identical R 1.5M, 1.8Y, 2Y mild ACR None Survived
4 20 M FHF Aunt Identical R 1M, 5M, 2Y Cholestasis Survived
5 58 M LC-C Sister Identical R 2M Hepatitis Survived
6 56 M LC-B/HCC Daughter Identical R 8M Vanishing BD Survived
7 56 M LC-B/HCC Daughter Identical R 9M (Re-LDLT) Poor quality Survived
8 56 M LC-B/HCC Wife Identical R 6M Mild ACR Survived
9 58 M LC-C/HCC Daughter Incompatible R 3W Hepatitis Survived
10 62 M LC-C Sister Compatible L 1.5M Moderate ACR Survived
11 41 M PBC Wife Identical R 1W, 1M (autopsy) Severe ACR Died (2M)
12 50 M LC-B Wife Identical R 10d (graft failure) Malcirculation Died (1M)
13 57 M LC-C/HCC Wife Identical R 10d, 2M (graft failure) Moderate ACR Died (2M)
14 47 M LC-Al Sister Identical R 3.8Y (liver cirrhosis) Poor quality Died (3.8Y)
15 51 M LC-C Sister Identical R 2.5Y (chronic liver failure) Biliary cirrhosis Died (2.5Y)
FHF fulminant hepatic failure, BA biliary atrasia, ACR acute cellular rejection, LC-B liver cirrhosis due to hepatitis B, LC-C liver cirrhosis due to
hepatitis C, LC-Al liver cirrhosis due to alcohol hepatitis, HCC hepatocellular carcinoma, PBC primary biliary cirrhosis, d days, M months, Y
years, LDLT living-donor liver transplantation
Table 2 Summary of results
Normal
regeneration
Acute graft
failure
Chronic graft
failure
Y chromosome -? ? ?
Hepatocyte antigen -- -
CK7 (bile duct) -- -
CD68 (macrophage) - Partial ?-
CD34 (hematopoietic) -? ?
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123In conclusion, in adult-to-adult LDLT, vigorous liver
regeneration occurs in graft livers. Involvement of extra-
hepatic cells in normal adult-to-adult liver regeneration
seems limited.
Open Access This article is distributed under the terms of the
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